CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $23,000 | -61.7% | 16,600 | -39.6% | 0.00% | – |
Q2 2022 | $60,000 | +7.1% | 27,500 | +57.1% | 0.00% | – |
Q1 2022 | $56,000 | -78.2% | 17,500 | -71.5% | 0.00% | -100.0% |
Q4 2021 | $257,000 | -64.5% | 61,300 | -31.1% | 0.00% | -50.0% |
Q3 2021 | $723,000 | -32.2% | 89,000 | -37.0% | 0.00% | -33.3% |
Q2 2021 | $1,067,000 | -42.7% | 141,300 | -34.2% | 0.00% | -40.0% |
Q1 2021 | $1,863,000 | +59.0% | 214,600 | +45.9% | 0.01% | +66.7% |
Q4 2020 | $1,172,000 | -24.6% | 147,100 | -24.6% | 0.00% | -25.0% |
Q3 2020 | $1,555,000 | +13.9% | 195,000 | +41.4% | 0.00% | 0.0% |
Q2 2020 | $1,365,000 | +59.8% | 137,900 | +24.8% | 0.00% | +33.3% |
Q1 2020 | $854,000 | +61.1% | 110,500 | -19.8% | 0.00% | +200.0% |
Q4 2019 | $530,000 | -1.1% | 137,700 | +29.2% | 0.00% | 0.0% |
Q3 2019 | $536,000 | -33.1% | 106,600 | -12.0% | 0.00% | -50.0% |
Q2 2019 | $801,000 | -19.5% | 121,200 | -7.8% | 0.00% | -33.3% |
Q1 2019 | $995,000 | -11.6% | 131,400 | -5.7% | 0.00% | 0.0% |
Q4 2018 | $1,126,000 | -48.1% | 139,400 | -17.2% | 0.00% | -40.0% |
Q3 2018 | $2,171,000 | -11.1% | 168,300 | -21.4% | 0.01% | -28.6% |
Q2 2018 | $2,441,000 | – | 214,151 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 450,000 | $846,000 | 0.90% |
Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |